A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...

These findings counter clinical trial results published in June which found that Paxlovid was safe to take but did not lessen ...

A study of human brain organoids suggested a complex relationship between herpes simplex virus 1 infection and tau, ...

But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who ...

A detailed examination of how patients respond to the drug at various times and doses provides greater context to a recent ...

A study indicates that longer Paxlovid treatments could improve long COVID symptoms in some patients, highlighting the need ...

An up-close look at how patients respond to the drug at different times and doses adds nuance to a recent finding that ...

Extended courses of Paxlovid may alleviate symptoms in some patients with long Covid, though its effectiveness varies widely.

A recent patient-led case series highlights the potential benefits of extended courses of Pfizer Inc's (NYSE:PFE) Paxlovid ...

A new study from UC San Francisco researchers indicates that an extended course of Paxlovid, an antiviral medication, may ...

An extended course of Paxlovid appears to help some patients with long Covid, according to research that suggests this treatment option holds promise for some of those struggling with debilitating ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.